CHARLES
LAWRIE
Hospital de Cruces
Barakaldo, EspañaPublications en collaboration avec des chercheurs de Hospital de Cruces (18)
2024
-
Identification of miRNAs and Their Target Genes Associated with Sunitinib Resistance in Clear Cell Renal Cell Carcinoma Patients
International Journal of Molecular Sciences, Vol. 25, Núm. 13
-
Predicting Survival of Metastatic Clear Cell Renal Cell Cancer Treated with VEGFR-TKI-Based Sequential Therapy
Cancers, Vol. 16, Núm. 16
2022
-
Clear Cell Renal Cell Carcinomas with Aggressive Behavior Display Low Intratumor Heterogeneity at the Histological Level
Current Urology Reports, Vol. 23, Núm. 6, pp. 93-97
-
SOX9 Triggers Different Epithelial to Mesenchymal Transition States to Promote Pancreatic Cancer Progression
Cancers, Vol. 14, Núm. 4
2021
2020
-
An integrative omics approach reveals involvement of BRCA1 in hepatic metastatic progression of colorectal cancer
Cancers, Vol. 12, Núm. 9, pp. 1-24
-
Identification of recurrent mutations in the microrna‐binding sites of b‐cell lymphoma‐ associated genes in follicular lymphoma
International Journal of Molecular Sciences, Vol. 21, Núm. 22, pp. 1-12
-
The urinary transcriptome as a source of biomarkers for prostate cancer
Cancers, Vol. 12, Núm. 2
2018
-
High levels of intratumor heterogeneity characterize the expression of epithelial-mesenchymal transition markers in high-grade clear cell renal cell carcinoma
Annals of Diagnostic Pathology, Vol. 34, pp. 27-30
-
Loss of PD-L1 (SP-142) expression characterizes renal vein tumor thrombus microenvironment in clear cell renal cell carcinoma
Annals of Diagnostic Pathology, Vol. 34, pp. 89-93
-
Mutational profiling can identify laryngeal dysplasia at risk of progression to invasive carcinoma
Scientific Reports, Vol. 8, Núm. 1
-
Noncoding RNA Expression and Targeted Next-Generation Sequencing Distinguish Tubulocystic Renal Cell Carcinoma (TC-RCC) from Other Renal Neoplasms
Journal of Molecular Diagnostics, Vol. 20, Núm. 1, pp. 34-45
-
Potential impact of PD-L1 (SP-142) immunohistochemical heterogeneity in clear cell renal cell carcinoma immunotherapy
Pathology Research and Practice, Vol. 214, Núm. 8, pp. 1110-1114
2017
-
DNMT1 is predictive of survival and associated with Ki-67 expression in R-CHOP-treated diffuse large B-cell lymphomas
Pathology, Vol. 49, Núm. 7, pp. 731-739
-
Expression and activity of angiotensin-regulating enzymes is associated with prognostic outcome in clear cell renal cell carcinoma patients
PLoS ONE, Vol. 12, Núm. 8
2016
2015
-
Low HIP1R mRNA and protein expression are associated with worse survival in diffuse large B-cell lymphoma patients treated with R-CHOP
Experimental and Molecular Pathology, Vol. 99, Núm. 3, pp. 537-545
2014
-
Targeted next-generation sequencing and non-coding RNA expression analysis of clear cell papillary renal cell carcinoma suggests distinct pathological mechanisms from other renal tumour subtypes
Journal of Pathology, Vol. 232, Núm. 1, pp. 32-42